The MIT-spinout thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy, and Parkinson’s disease. Famed investor Steve ...
Neuroscientists use cellular and molecular biology, anatomy and physiology ... in pain perception or the underlying cause of Parkinson’s disease. Computer simulations, imaging, and other ...
Neuroscientists use cellular and molecular biology, anatomy and physiology ... in pain perception or the underlying cause of Parkinson’s disease. Computer simulations, imaging, and other ...
This is a particularly exciting time for DBS, as the demonstration of the long-term efficacy of DBS as a treatment for movement disorders such as Parkinson's disease, tremor and dystonia ...
Long term treatment and disease severity change brain responses to levodopa in Parkinson’s disease
Conclusions: It is concluded that long term levodopa treatment and disease severity affect the physiology of dopaminergic pathways, producing altered responses to levodopa in brain regions associated ...
Introduction Selecting the ideal contact to apply subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease is time-consuming and ... chosen contact was as follows: ERNA 80%, anatomy ...
Aberrant accumulation of intracellular ubiquitin-positive inclusions has been implicated to a variety of neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), ...
The skin will absorb some types of medications including: The skin interacts with the body’s immune system in many ways to protect the body from infection, serving as a physical barrier to disease ...
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback